The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").
Biome Technologies plc
("Biome", "the Company" or "the Group")
Settlement Agreement
Biome Technologies plc announces that it has signed a settlement agreement with third parties regarding legacy technology licensing arrangements involving the use of part of Biome's historic technology (the "Settlement Agreement"). Under the terms of the Settlement Agreement, Biome will receive a payment of £450,000, such payment to be received within 14 business days of signing of the Settlement Agreement.
Various agreements which have been in place since 2000 provided for royalties to be paid by the third parties to Biome for the use of certain Biome technologies relating to the legacy Aquasol business. The patents associated with this technology are no longer in force and, pursuant to the Settlement Agreement, Biome and the third parties have agreed to a mutual release from all obligations under the agreements.
The funds received under the Settlement Agreement will be deployed for normal business purposes.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.